1,3-Dibromopropane → 9-[3-(1-Azetidinyl)propyl]-2-(butyloxy)-8-(methyloxy)-9H-purin-6-amine
Reaction equation
F[C:2](F)(F)[C:3](O)=O.[CH2:8]([O:12][C:13]1[NH:14][C:15]([NH2:24])=[C:16]2[C:20]([N:21]=1)=[N:19][C:18]([O:22][CH3:23])=[N:17]2)[CH2:9][CH2:10][CH3:11].C(=O)([O-])[O-].[K+].[K+].BrCCCBr.N1CCC1.[CH2:40]([N:42]([CH2:45][CH3:46])[CH2:43]C)C>CN(C=O)C>[N:42]1([CH2:40][CH2:2][CH2:3][N:19]2[C:18]([O:22][CH3:23])=[N:17][C:16]3[C:20]2=[N:21][C:13]([O:12][CH2:8][CH2:9][CH2:10][CH3:11])=[N:14][C:15]=3[NH2:24])[CH2:43][CH2:46][CH2:45]1Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 50 °C
Procedure
2-(Butyloxy)-8-(methyloxy)-1H-purin-6-amine trifluoroacetate (100 mg, 0.285 mmol) was dissolved in DMF (1 ml) and potassium carbonate (98 mg, 0.712 mmol) was added. The reaction mixture was stirred at 50° C. under nitrogen for 1 hour and then cooled to room temperature. 1,3-Dibromopropane (0.029 ml, 0.285 mmol) was added and after stirring for a further 40 mins. azetidine (0.038 ml, 0.569 mmol) and triethylamine (0.079 ml, 0.569 mmol) in DMF (1 ml) were added. The reaction mixture was then stirred for a further 18 hours. The solvent was removed and the residue was partitioned between dichloromethane (2 ml) and water (2 ml). The layers were separated using a hydrophobic frit and the aqueous phase was re-extracted with DCM (2 ml). The combined organic extracts were concentrated and the residue was dissolved in 1:1 MeOH:DMSO (1 ml) and purified by MDAP (Method A). The product containing fractions were evaporated under a stream of nitrogen to give the title compound as a white solid (13 mg).
Workup
- temperaturecooled to room temperature
- stirringafter stirring for a further 40 mins
- stirringThe reaction mixture was then stirred for a further 18 hours
- customThe solvent was removed
- customthe residue was partitioned between dichloromethane (2 ml) and water (2 ml)
- customThe layers were separated
- extractionthe aqueous phase was re-extracted with DCM (2 ml)
- concentrationThe combined organic extracts were concentrated
- dissolutionthe residue was dissolved in 1:1 MeOH
- customDMSO (1 ml) and purified by MDAP (Method A)
- additionThe product containing fractions
- customwere evaporated under a stream of nitrogen
Sources & evidence
- ORD record
- ord-572a701d4fc54bfba833f8d7e8471867
- Source dataset
- uspto-grants-2014_07
- Patent number
- US08765772B2
Reaction notes
Loading…